Other ways to search: Events Calendar | UTHSC

Optimizing Epilepsy Treatments: Stiripentol’s Role in Dravet Syndrome

|

James Wheless, MD, FAAP, FAAN, FAES, Le Bonheur Chair in Pediatric Neurology at the University of Tennessee Health Science Center, shared insights on his presentation from AES 2024, focusing on stiripentol, an FDA-approved treatment for Dravet syndrome.

Top Publishers